Critical heart condition during pregnancy : critical care obstetrics.

Cardiac Critical Illness is a volume in the Critical Care Obstetrics series.It's a novel reference to educate physicians, nurses, and all allied healthcare personnel caring for pregnant women with various health compromises specific to cardiac complications.

Bibliographic Details
Corporate Author: ScienceDirect (Online service)
Format: eBook
Language:English
Published: [S.l.] : Academic Press, 2024.
Series:Criticial care in obstetrics
Subjects:
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • Front Cover
  • Critical Heart Condition During Pregnancy
  • Critical Heart Condition During Pregnancy: Critical Care Obstetrics
  • Copyright
  • Contents
  • Contributors
  • Preface
  • 1
  • The cardio-obstetric team
  • Introduction
  • Components of the cardio-obstetric team
  • Purpose of the cardio-obstetric team
  • Preconception assessment of patients with cardiac disease
  • mWHO class I
  • mWHO class II
  • mWHO class II-III
  • mWHO class III
  • mWHO class IV
  • Collaborative antenatal assessment
  • Multidisciplinary conferences
  • Postdelivery follow-up
  • Research and education
  • Training
  • Developing a cardio-obstetrics service
  • Organizational culture and future vision
  • Conclusion
  • References
  • 2
  • Pregnancy induced heart physiological alteration
  • Introduction
  • Heart remodeling (position and size)
  • Heart rate
  • Cardiac output
  • Blood volume changes
  • Systemic vascular resistance
  • Arterial blood pressure
  • Influence body position
  • Conclusion
  • References
  • 3
  • Critical heart condition during pregnancy
  • Physiological changes of pregnancy
  • Hypertensive disorders associated with pregnancy
  • Hypotensive sintomas de hipotension
  • Symptoms and signs in preeclampsia and eclampsia
  • Heart valve disease
  • Other heart problems that could develop during pregnancy
  • Arrhythmias
  • References
  • 4
  • Anesthesia and analgesia for the critically ill obstetric patient with cardiac disease
  • Introduction
  • Risk stratification
  • WHO group I
  • WHO group II
  • WHO group III
  • WHO group IV
  • Identification of heart disease in pregnancy
  • Physiological changes during delivery
  • Decision-making and delivery planning
  • Monitoring
  • General principles of anesthetic management
  • Analgesia for vaginal delivery
  • Neuraxial anesthesia for caesarean section delivery.
  • General anesthesia for caesarean section delivery-general principles
  • Peripartum cardiovascular support-pharmacological
  • Obstructive lesions
  • Regurgitant lesions
  • Ischemic heart disease
  • Pulmonary hypertension
  • Acute aortic aneurysm and dissection
  • Right-to-left shunt
  • Left-to-right shunt
  • Peripartum cardiovascular support-nonpharmacological
  • Postpartum care
  • References
  • 5
  • Anticoagulation in pregnancy
  • Introduction
  • Risk factors for pregnancy-related VTE
  • Anticoagulant therapy in pregnancy
  • Heparins
  • Vitamin K antagonist
  • Direct oral anticoagulant
  • Danaparoid
  • Fondaparinux
  • Other anticoagulants
  • Indications of anticoagulation in pregnancy
  • Preconception management of women already using anticoagulants when planning pregnancy
  • Previous VTE
  • Women with Mechanical heart valve
  • Prevention of pregnancy-related VTE
  • Women with a personal history of VTE
  • Thromboprophylaxis in women with inherited thrombophilia
  • Women undergoing assisted reproductive technology
  • Thromboprophylaxis after caesarean section
  • Prevention of pregnancy loss
  • Prevention in women with antiphospholipid Syndrome
  • Management of acute venous thromboembolism during pregnancy
  • Acute VTE during pregnancy
  • Thrombolysis for pulmonary embolism in pregnancy
  • Peripartum management
  • Anticoagulant therapy in breastfeeding women
  • Conclusions
  • References
  • 6
  • Pregnancy and valvular heart disease
  • Introduction
  • Hemodynamic changes during pregnancy
  • Evaluation and risk assessment
  • Mitral stenosis
  • Aortic stenosis
  • Women with prosthetic valves
  • Stenotic valve disease
  • Mitral stenosis
  • Aortic stenosis
  • Regurgitant valve disease
  • Delivery and postpartum management
  • Anesthetic considerations
  • Intrapartum care
  • Mode of delivery
  • Endocarditis risk
  • Postpartum management
  • Oxytocic drugs.
  • Anticoagulation and hemorrhage
  • Lactation
  • Contraception
  • References
  • 7
  • Adult congenital heart disease in pregnancy
  • Introduction
  • Preconception counseling
  • Contraindications to pregnancy
  • Determinants of fetal outcome
  • Risk of recurrence of congenital heart defects in fetus
  • Investigations
  • Specific lesions
  • Acyanotic congenital heart diseases
  • Cyanotic congenital heart disease
  • Tetralogy of Fallot
  • Transposition of the great arteries
  • Truncus arteriosus
  • Ebstein's anomaly
  • Univentricular heart
  • Management
  • Antenatal care and prevention of complications
  • Cardiac medications during pregnancy
  • Thromboembolism and pregnancy
  • Delivery
  • Antibiotic prophylaxis
  • Intensive care management
  • Conclusion
  • References
  • 8
  • Peripartum cardiomyopathy
  • Peripartum cardiomyopathy case definition
  • Epidemiology
  • Risk factors
  • Pathophysiology
  • Clinical manifestations
  • Therapeutic strategies
  • Acute phase
  • Chronic phase
  • References
  • 9
  • Acute coronary syndrome during pregnancy
  • Incidence and risk factors
  • Diagnosis
  • Management
  • Conclusion
  • References
  • 10
  • Pulmonary hypertension in pregnancy
  • Introduction
  • Definition
  • Burden of disease
  • Physiological changes and impact on PAH
  • Diagnosis
  • Symptoms/signs
  • Risk stratification
  • Counseling and contraceptives
  • Women who get pregnant
  • Approach to treatment
  • Supportive measures
  • Pharmacological treatment of PAH
  • Calcium channel blockers
  • Pulmonary hypertension specific therapies
  • Endothelin receptor antagonists
  • Phosphodiesterase 5 inhibitors and guanylate cyclase stimulators
  • Inhaled nitric oxide
  • PAH during pregnancy
  • Mode of delivery
  • Delivery location
  • Anesthetic perspective
  • RVAD/ECMO/lung transplant
  • Postpartum
  • Conclusion
  • References
  • 11
  • Arrythmias in pregnancy and management.
  • Introduction
  • Cardiovascular adaptations in pregnancy
  • Mechanisms of arrhythmia
  • Types of arrhythmia during pregnancy
  • Supraventricular arrhythmias
  • Atrial fibrillation and flutter
  • Ventricular arrhythmias
  • Bradyarrhythmias
  • Approach to the pregnant woman with palpitations
  • History
  • Investigations
  • Principles of management of arrhythmias in pregnancy
  • Treatment of specific arrhythmias in pregnancy
  • Hemodynamically unstable arrhythmia
  • Benign arrhythmias
  • Supraventricular tachycardia
  • Atrial fibrillation and atrial flutter
  • Ventricular tachyarrhythmias
  • Invasive interventions
  • Postpartum considerations
  • Cardiac arrest in pregnancy
  • Inherited arrhythmia syndromes
  • Fetal arrhythmias in pregnancy
  • Tachyarrhythmias
  • Bradyarrhythmias
  • Conclusions
  • References
  • 12
  • Endocarditis in pregnancy
  • Introduction
  • Definition of endocarditis
  • History of diagnosis of IE
  • Diagnosis of infective endocarditis
  • Confirmation of diagnosis-in pregnancy
  • Management of IE
  • Management of IE for pregnancy
  • Treatment
  • Antibiotics
  • Surgery
  • Complications
  • Epidemiology of infective endocarditis
  • Types of patients
  • Risks
  • Prevalence
  • Conclusion
  • References
  • 13
  • Cardiopulmonary resuscitation in pregnancy
  • Introduction
  • Epidemiology of maternal cardiac arrest
  • Conduct of resuscitation
  • Activation of the resuscitation team
  • Basic life support
  • Perimortem caesarean section
  • Advanced life support
  • Iatrogenic causes
  • ECMO and ECPR
  • Survival and postresuscitation care
  • Somatic support
  • Human factors and preparation for maternal cardiac arrest
  • Conclusions
  • References
  • 14
  • Cardiac surgery and pregnancy
  • Cardiac surgery and pregnancy
  • Rheumatic fever
  • Physiological changes during pregnancy
  • Comprehensive evaluation
  • Maternal risk
  • Fetal risk.
  • Categorization and management of cardiovascular complications during pregnancy
  • High-risk
  • Intermediate-risk
  • Low-risk
  • Drugs and pregnancy
  • Arrhythmias
  • Thrombosis
  • Congenital cardiomyopathy
  • Shunts
  • Bicuspid aorta
  • Aortic coarctation
  • Pulmonary stenosis
  • Eisenmenger
  • Tetralogy of Fallot
  • Transpocición de grandes arterias (TGA)
  • Ebstein's
  • Marfan's
  • Aortic dissection
  • Hypertrophic cardiomyopathy
  • Dilated cardiomyopathy
  • Peripartum
  • Age
  • Myocardial infarction
  • Rheumatic disease
  • Pregnancy and valve replacement
  • Conclusion
  • References
  • 15
  • Heart failure in pregnancy
  • Introduction
  • General considerations
  • Hemodynamic changes during pregnancy
  • Hemodynamic changes during labor and delivery
  • Pathophysiology
  • Myocardial systolic function
  • Neurohormonal activation
  • Renin-angiotensin-aldosterone system
  • Sympathetic nervous system
  • Natriuretic peptides
  • Antidiuretic hormone (vasopressin)
  • Endothelins
  • Maternal and fetal risks
  • Causes of heart failure during pregnancy
  • Clinical signs
  • Investigations
  • Chest X-ray and ECG
  • Echocardiography
  • B-type natriuretic peptide
  • Treatment
  • Drug therapies
  • Diuretics
  • Vasodilator therapy
  • Angiotensin converting enzyme inhibitors
  • Beta-blockers
  • Spironolactone
  • Anticoagulation
  • Bromocriptine
  • Inotropes
  • Mechanical circulatory support
  • The mode of delivery
  • Prognosis
  • References
  • 16
  • Cardiovascular medications in critically ill pregnant patients
  • Introduction
  • Cardiovascular medications during pregnancy
  • Antiarrhythmic drugs
  • Antihypertensive drugs
  • Diuretic in pregnancy
  • Anticoagulation and antiplatelet therapy
  • Drugs for heart failure
  • Drugs for coronary artery disease during pregnancy
  • Lipid-lowering agents during pregnancy
  • Drugs for pulmonary hypertension during pregnancy.